Turning Point Brands Canada Becomes Exclusive Distributor for VPRB's HoneyStick in Canada

Business by 2FIRSTS.ai
Jan.09.2024
Turning Point Brands Canada Becomes Exclusive Distributor for VPRB's HoneyStick in Canada
VPR Brands announces Turning Point Brands Canada as the exclusive distributor of its HoneyStick products in Canada.

VPR Brands (OTC: VPRB) recently announced that Turning Point Brands Canada (TPB) will serve as the exclusive distributor for its HoneyStick products in Canada.

 

VPR Brands (VPRB) is an e-cigarette manufacturer dedicated to introducing innovative products.

 

TPB is a Canadian marketing and distribution company in the field of tobacco, e-cigarettes, and alternative products.

 

HoneyStick is set to join TPB Canada's portfolio of leading global brand management, alongside iconic brands such as Zig-Zag, Clipper, Choice Leaf, HMP, Rebound, and Evolve, to enter the Canadian market.

 

In the future, TPB Canada will streamline the retail process by centralizing ordering, logistics, and warehousing in one location. This will ensure a steady supply of HoneyStick products and reduce delivery times, enabling faster product delivery across Canada.

 

Currently, HoneyStick has launched on the Canadian e-commerce platform tpbmarketplace. However, it is either marked as "sold out" or yet to be available on several other Canadian e-commerce platforms.

 

Mikail Fancy, Chief Operating Officer of Turning Point Brands Canada, expressed enthusiasm over the partnership with VPR Brands to bring HoneyStick to a wider audience in Canada. Fancy highlighted the combination of their expertise in marketing, sales, distribution, and logistics, along with the quality and innovation of HoneyStick products, as a perfect match. He emphasized their commitment to providing excellent service and support for retailers and consumers.

 

Daniel Hoff, Chief Operating Officer of VPR Brands, has stated that the collaboration with Turning Point Brands Canada is a significant milestone for HoneyStick in Canada. Their strong distribution network and successful experience in marketing, sales, and customer service make them an ideal partner to enhance our brand's presence and accessibility nationwide.

 

VPR is currently involved in a significant case regarding a legal dispute with IMiracle (Heaven Gifts). The main point of contention revolves around the usage rights of the term "Elf" on e-cigarette products.

 

VPR filed a lawsuit in October 2022 against the distributor Shenzhen Weibo Li Technology Co., Ltd and the manufacturer iMiracle (HK) Limited, alleging infringement of VPR's trademark rights on ELF during the sales of Elfbar. Elfbar is the most popular disposable e-cigarette brand among young users.

 

In response, Judge Cannon in the United States issued a temporary injunction on Chinese companies in February 2023, prohibiting them from selling any e-cigarette products bearing the name ELFBAR. Judge Cannon stated that there is currently "no dispute" that these companies intentionally infringed upon VPR's trademark rights.

 

Shenzhen V-Perfect and iMiracle have submitted their first document claiming that they can prove V-Perfect is not the original user of the ELF trademark. According to the documents submitted by these two companies on April 24th, they have discovered the true owner of the ELF trademark, another Chinese company called GD Sigelei Electronic Tech. This company first used the "ELF" to sell e-cigarette products in April 2016, almost a year and a half earlier than V-Perfect's first batch of ELF products.

 

In March of this year, two Chinese companies signed a trademark transfer agreement, claiming to have transferred the rights to the Elf trademark to iMiracle. Based on this, they have requested Judge Cannon to revoke the temporary injunction.

 

Another important document claims that VPR has utilized a court order prohibiting them from manufacturing ELFBAR in order to seek market share. According to the document from May, VPR has launched a "blatantly imitated" ELFBAR disposable e-cigarette, clearly copying iMiracle's product. Both of these Chinese companies argue that these inferior counterfeit products will confuse consumers, ultimately leading to ELFBAR losing market share and reputation.

 

Although both parties have informed the mediators that Judge Cannon's decision on these two motions will "guide their positions for settlement," the case remains at a standstill, waiting for the Chinese companies to appeal to the Federal Circuit in an attempt to overturn the injunction. These two Chinese companies are dissatisfied with the temporary ban and stated in their submission to the Federal Circuit that the injunction is erroneous and has resulted in them losing millions of dollars.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
Special Report | From New York to Washington: How FDA’s Tobacco Center Is Reworking Product Review
FDA’s Center for Tobacco Products is reshaping how it approaches tobacco product review. Based on 2Firsts’ on-site reporting in New York and Washington, this report traces CTP’s emerging direction: stronger links between PMTA and tobacco harm reduction, more category-specific review, greater emphasis on decision-relevant science, more predictable timelines and expanded use of sPMTA for product modifications. CTP also acknowledged major constraints, including just nine PMTA review teams, persistent backlogs and limits on hiring capacity.
Regulations
Oct.08
Russia Expands Temporary Administration of JTI Assets in Second Round: From Four to All Seven Russian Entities, With Approximately $9.5 Billion in Related Assets
Russia Expands Temporary Administration of JTI Assets in Second Round: From Four to All Seven Russian Entities, With Approximately $9.5 Billion in Related Assets
Japan Tobacco Inc. (JT) confirmed on November 9, 2026, that all seven of its Russian entities had been placed under temporary administration after a second presidential decree added three companies to the four designated a day earlier. The additional entities are associated with importing, management, holdings and the former supply of Ploom heated-tobacco devices. JT disclosed approximately ¥1.5 trillion in Russian business-related assets as of September 30, including ¥360 billion in cash and deposits, and approximately ¥200 billion in liabilities. Under its revised FY2026 forecast, Russia accounts for about 25% of adjusted operating profit. JT said operations in Russia were continuing, while the financial impact remained under assessment.
company
Nov.09
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives
Texas Extends Tobacco Tax Interpretation to a 6-Methylnicotine Product, Citing VELO Ruling
Texas Extends Tobacco Tax Interpretation to a 6-Methylnicotine Product, Citing VELO Ruling
The Texas Comptroller of Public Accounts ruled in September 2026 that a combustible product made with non-tobacco plant material and 6-methylnicotine (6-MN), a synthetic nicotine analog, qualifies as a taxable tobacco product. The applicant said the product contained neither tobacco leaf nor measurable conventional nicotine. The determination applies reasoning from a May Texas Supreme Court decision involving VELO nicotine pouches, finding that the plant material and 6-MN together perform the functions of tobacco in a conventional smoking product. The ruling carries applicable tax, licensing and reporting obligations but is limited to the facts submitted by the taxpayer. It does not establish a blanket tax classification for all 6-MN products or extend the same conclusion to e-cigarettes.
Regulations
Nov.06
Reynolds Puts Nearly 183,000 U.S. Contracted Outlets Under Age-Verification Rules, Covering 94% of Volume — Can It Shift an Unauthorized Vape Market?
Reynolds Puts Nearly 183,000 U.S. Contracted Outlets Under Age-Verification Rules, Covering 94% of Volume — Can It Shift an Unauthorized Vape Market?
Reynolds American says nearly 183,000 U.S. retail outlets are under contract, with its Retail Marketing Plan Contract covering about 94% of company volume and requiring point-of-sale age verification. The company combines those contracts with We Card, TruAge, NACS-linked infrastructure and POS integration, while enhanced Vuse Pro retail rules add ID scanning, purchase limits and stronger underage-sales accountability. The initial Vuse Pro rollout targets about 50,000 stores. The system is taking shape as unauthorized vapor products remain dominant in parts of the U.S. market: a 2026 study estimated they accounted for 69.4% of tracked brick-and-mortar e-cigarette dollar sales in December 2025.
Special Report
Oct.15
Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Product | Four CrossBar 20K 13mL High-Puff Vapes Listed on Pennsylvania's ENDS Directory, Rated for Up to 20,000 Puffs
Four CrossBar 20K disposable e-cigarettes appeared on Pennsylvania's 163-entry ENDS directory ahead of enforcement beginning October 19, 2026. The devices feature 13mL e-liquid reservoirs, 50mg/mL nicotine, 2,000mAh batteries and 0.9Ω mesh coils, with advertised puff counts of up to 20,000. CrossBar was the only modern high-puff disposable series among the directory's 15 disposable entries. Its packaging emphasizes New York design and Japanese-origin flavoring, while historical CrossBar records identify a registered U.S. tobacco manufacturing-related establishment. The link between the newer 13mL devices and earlier 1.3mL PMTA filings remains unconfirmed.
product
Oct.26